Eli Lilly's Antibody Combo Wins FDA Approval zithromax online for Mild to Moderate COVID-19
This combination therapy has been authorized for the treatment of mild to moderate COVID-19 in patients aged 12 and older who are at high risk for progressing to severe COVID-19 and/or hospitalization.